Leesa Gentry - Chief Clinical Officer at RenovoRx, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Clinical Officer
Stock Symbol
RNXT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Leesa Gentry since 11/9/2023

Holdings reported by Leesa Gentry for RenovoRx, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Options 190K Mar 6, 2024 Direct Common Stock

Transactions reported by Leesa Gentry for RenovoRx, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.